YTHDF1 Control of Dendritic Cell Cross-Priming as a Possible Target of Cancer Immunotherapy

Biochemistry. 2019 Apr 16;58(15):1945-1946. doi: 10.1021/acs.biochem.9b00200. Epub 2019 Apr 3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cross-Priming*
  • Dendritic Cells
  • Humans
  • Immunotherapy
  • Methylation
  • Neoplasms*
  • RNA, Messenger
  • RNA-Binding Proteins

Substances

  • RNA, Messenger
  • RNA-Binding Proteins
  • YTHDF1 protein, human